Omics Based Clinical Trials Market, Global Outlook and Forecast 2024-2031

Report ID: 1647518 | Published Date: Oct 2024 | No. of Page: 67 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Omics Based Clinical Trials Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Omics Based Clinical Trials Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Omics Based Clinical Trials Overall Market Size
    2.1 Global Omics Based Clinical Trials Market Size: 2021 VS 2028
    2.2 Global Omics Based Clinical Trials Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Omics Based Clinical Trials Players in Global Market
    3.2 Top Global Omics Based Clinical Trials Companies Ranked by Revenue
    3.3 Global Omics Based Clinical Trials Revenue by Companies
    3.4 Top 3 and Top 5 Omics Based Clinical Trials Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Omics Based Clinical Trials Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Omics Based Clinical Trials Players in Global Market
        3.6.1 List of Global Tier 1 Omics Based Clinical Trials Companies
        3.6.2 List of Global Tier 2 and Tier 3 Omics Based Clinical Trials Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Omics Based Clinical Trials Market Size Markets, 2021 & 2028
        4.1.2 Interventional Studies
        4.1.3 Observational Studies
        4.1.4 Expanded Access Studies
    4.2 By Type - Global Omics Based Clinical Trials Revenue & Forecasts
        4.2.1 By Type - Global Omics Based Clinical Trials Revenue, 2017-2022
        4.2.2 By Type - Global Omics Based Clinical Trials Revenue, 2023-2028
        4.2.3 By Type - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Omics Based Clinical Trials Market Size, 2021 & 2028
        5.1.2 Oncology
        5.1.3 Cardiology
        5.1.4 Respiratory Diseases
        5.1.5 Skin Diseases
        5.1.6 CNS Diseases
        5.1.7 Immunology
        5.1.8 Genetic Diseases
        5.1.9 Other Indications
    5.2 By Application - Global Omics Based Clinical Trials Revenue & Forecasts
        5.2.1 By Application - Global Omics Based Clinical Trials Revenue, 2017-2022
        5.2.2 By Application - Global Omics Based Clinical Trials Revenue, 2023-2028
        5.2.3 By Application - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Omics Based Clinical Trials Market Size, 2021 & 2028
    6.2 By Region - Global Omics Based Clinical Trials Revenue & Forecasts
        6.2.1 By Region - Global Omics Based Clinical Trials Revenue, 2017-2022
        6.2.2 By Region - Global Omics Based Clinical Trials Revenue, 2023-2028
        6.2.3 By Region - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Omics Based Clinical Trials Revenue, 2017-2028
        6.3.2 US Omics Based Clinical Trials Market Size, 2017-2028
        6.3.3 Canada Omics Based Clinical Trials Market Size, 2017-2028
        6.3.4 Mexico Omics Based Clinical Trials Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Omics Based Clinical Trials Revenue, 2017-2028
        6.4.2 Germany Omics Based Clinical Trials Market Size, 2017-2028
        6.4.3 France Omics Based Clinical Trials Market Size, 2017-2028
        6.4.4 U.K. Omics Based Clinical Trials Market Size, 2017-2028
        6.4.5 Italy Omics Based Clinical Trials Market Size, 2017-2028
        6.4.6 Russia Omics Based Clinical Trials Market Size, 2017-2028
        6.4.7 Nordic Countries Omics Based Clinical Trials Market Size, 2017-2028
        6.4.8 Benelux Omics Based Clinical Trials Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Omics Based Clinical Trials Revenue, 2017-2028
        6.5.2 China Omics Based Clinical Trials Market Size, 2017-2028
        6.5.3 Japan Omics Based Clinical Trials Market Size, 2017-2028
        6.5.4 South Korea Omics Based Clinical Trials Market Size, 2017-2028
        6.5.5 Southeast Asia Omics Based Clinical Trials Market Size, 2017-2028
        6.5.6 India Omics Based Clinical Trials Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Omics Based Clinical Trials Revenue, 2017-2028
        6.6.2 Brazil Omics Based Clinical Trials Market Size, 2017-2028
        6.6.3 Argentina Omics Based Clinical Trials Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Omics Based Clinical Trials Revenue, 2017-2028
        6.7.2 Turkey Omics Based Clinical Trials Market Size, 2017-2028
        6.7.3 Israel Omics Based Clinical Trials Market Size, 2017-2028
        6.7.4 Saudi Arabia Omics Based Clinical Trials Market Size, 2017-2028
        6.7.5 UAE Omics Based Clinical Trials Market Size, 2017-2028
7 Players Profiles
    7.1 Parexel International Corporation
        7.1.1 Parexel International Corporation Corporate Summary
        7.1.2 Parexel International Corporation Business Overview
        7.1.3 Parexel International Corporation Omics Based Clinical Trials Major Product Offerings
        7.1.4 Parexel International Corporation Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.1.5 Parexel International Corporation Key News
    7.2 Pharmaceutical Product Development (PPD)
        7.2.1 Pharmaceutical Product Development (PPD) Corporate Summary
        7.2.2 Pharmaceutical Product Development (PPD) Business Overview
        7.2.3 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Major Product Offerings
        7.2.4 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.2.5 Pharmaceutical Product Development (PPD) Key News
    7.3 Charles River Laboratory
        7.3.1 Charles River Laboratory Corporate Summary
        7.3.2 Charles River Laboratory Business Overview
        7.3.3 Charles River Laboratory Omics Based Clinical Trials Major Product Offerings
        7.3.4 Charles River Laboratory Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.3.5 Charles River Laboratory Key News
    7.4 ICON plc
        7.4.1 ICON plc Corporate Summary
        7.4.2 ICON plc Business Overview
        7.4.3 ICON plc Omics Based Clinical Trials Major Product Offerings
        7.4.4 ICON plc Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.4.5 ICON plc Key News
    7.5 SGS SA
        7.5.1 SGS SA Corporate Summary
        7.5.2 SGS SA Business Overview
        7.5.3 SGS SA Omics Based Clinical Trials Major Product Offerings
        7.5.4 SGS SA Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.5.5 SGS SA Key News
    7.6 Eli Lilly and Company
        7.6.1 Eli Lilly and Company Corporate Summary
        7.6.2 Eli Lilly and Company Business Overview
        7.6.3 Eli Lilly and Company Omics Based Clinical Trials Major Product Offerings
        7.6.4 Eli Lilly and Company Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.6.5 Eli Lilly and Company Key News
    7.7 Pfizer
        7.7.1 Pfizer Corporate Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Omics Based Clinical Trials Major Product Offerings
        7.7.4 Pfizer Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.7.5 Pfizer Key News
    7.8 Covance
        7.8.1 Covance Corporate Summary
        7.8.2 Covance Business Overview
        7.8.3 Covance Omics Based Clinical Trials Major Product Offerings
        7.8.4 Covance Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.8.5 Covance Key News
    7.9 Rebus Bio
        7.9.1 Rebus Bio Corporate Summary
        7.9.2 Rebus Bio Business Overview
        7.9.3 Rebus Bio Omics Based Clinical Trials Major Product Offerings
        7.9.4 Rebus Bio Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.9.5 Rebus Bio Key News
    7.10 Novo Nordisk
        7.10.1 Novo Nordisk Corporate Summary
        7.10.2 Novo Nordisk Business Overview
        7.10.3 Novo Nordisk Omics Based Clinical Trials Major Product Offerings
        7.10.4 Novo Nordisk Omics Based Clinical Trials Revenue in Global Market (2017-2022)
        7.10.5 Novo Nordisk Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Omics Based Clinical Trials Market Opportunities & Trends in Global Market
    Table 2. Omics Based Clinical Trials Market Drivers in Global Market
    Table 3. Omics Based Clinical Trials Market Restraints in Global Market
    Table 4. Key Players of Omics Based Clinical Trials in Global Market
    Table 5. Top Omics Based Clinical Trials Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Omics Based Clinical Trials Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Omics Based Clinical Trials Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Omics Based Clinical Trials Product Type
    Table 9. List of Global Tier 1 Omics Based Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Omics Based Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Omics Based Clinical Trials Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Omics Based Clinical Trials Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Omics Based Clinical Trials Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Omics Based Clinical Trials Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Omics Based Clinical Trials Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Omics Based Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 30. Parexel International Corporation Corporate Summary
    Table 31. Parexel International Corporation Omics Based Clinical Trials Product Offerings
    Table 32. Parexel International Corporation Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 33. Pharmaceutical Product Development (PPD) Corporate Summary
    Table 34. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Product Offerings
    Table 35. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 36. Charles River Laboratory Corporate Summary
    Table 37. Charles River Laboratory Omics Based Clinical Trials Product Offerings
    Table 38. Charles River Laboratory Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 39. ICON plc Corporate Summary
    Table 40. ICON plc Omics Based Clinical Trials Product Offerings
    Table 41. ICON plc Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 42. SGS SA Corporate Summary
    Table 43. SGS SA Omics Based Clinical Trials Product Offerings
    Table 44. SGS SA Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 45. Eli Lilly and Company Corporate Summary
    Table 46. Eli Lilly and Company Omics Based Clinical Trials Product Offerings
    Table 47. Eli Lilly and Company Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 48. Pfizer Corporate Summary
    Table 49. Pfizer Omics Based Clinical Trials Product Offerings
    Table 50. Pfizer Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 51. Covance Corporate Summary
    Table 52. Covance Omics Based Clinical Trials Product Offerings
    Table 53. Covance Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 54. Rebus Bio Corporate Summary
    Table 55. Rebus Bio Omics Based Clinical Trials Product Offerings
    Table 56. Rebus Bio Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 57. Novo Nordisk Corporate Summary
    Table 58. Novo Nordisk Omics Based Clinical Trials Product Offerings
    Table 59. Novo Nordisk Omics Based Clinical Trials Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Omics Based Clinical Trials Segment by Type in 2021
    Figure 2. Omics Based Clinical Trials Segment by Application in 2021
    Figure 3. Global Omics Based Clinical Trials Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Omics Based Clinical Trials Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Omics Based Clinical Trials Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Omics Based Clinical Trials Revenue in 2021
    Figure 8. By Type - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 12. US Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 16. Germany Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 17. France Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 24. China Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 28. India Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 30. Brazil Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Omics Based Clinical Trials Revenue Market Share, 2017-2028
    Figure 33. Turkey Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Omics Based Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 37. Parexel International Corporation Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Charles River Laboratory Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. ICON plc Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. SGS SA Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Eli Lilly and Company Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pfizer Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Covance Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Rebus Bio Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Novo Nordisk Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Omics Based Clinical Trials Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Omics Based Clinical Trials Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Omics Based Clinical Trials Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports